- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 205/04 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 205/04
Total number of patents in this class: 1267
10-year publication summary
|
78
|
82
|
85
|
78
|
92
|
86
|
95
|
92
|
70
|
49
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10725 |
39 |
| Bristol-myers Squibb Company | 4855 |
23 |
| Takeda Pharmaceutical Company Limited | 2706 |
21 |
| Janssen Pharmaceutica N.V. | 3362 |
20 |
| Incyte Corporation | 1024 |
20 |
| F. Hoffmann-La Roche AG | 7947 |
16 |
| AstraZeneca AB | 2895 |
16 |
| Ono Pharmaceutical Co., Ltd. | 431 |
15 |
| Genentech, Inc. | 4001 |
13 |
| Boehringer Ingelheim International GmbH | 4646 |
13 |
| Abbvie Inc. | 1801 |
13 |
| Allergan, Inc. | 2337 |
12 |
| Epicentrx, Inc. | 91 |
12 |
| Autobahn Therapeutics, Inc. | 41 |
12 |
| Araxes Pharma LLC | 92 |
11 |
| Biogen MA Inc. | 908 |
11 |
| Incyte Holdings Corporation | 667 |
11 |
| Corteva Agriscience LLC | 2696 |
11 |
| Northrop Grumman Systems Corporation | 2935 |
10 |
| Integrative Research Laboratories Sweden AB | 36 |
10 |
| Other owners | 958 |